Search Protocols under revision. Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupOther Solid Tumors (ped.)DiseaseNeuroblastomaSubgroupAge < 1 yearAge > 1 yearMYCN amplificationWeight < 10 kgICD10C47.-MeSHNeuroblastomaSequenceAntineoplastic therapySubstanceCarboplatinCisplatinCyclophosphamideDacarbazineDoxorubicinEtoposide phosphateIfosfamideIsotretinoinMelphalanTopotecanVincristineVindesineSubstanceCarboplatinCisplatinCyclophosphamideDacarbazineDoxorubicinEtoposide phosphateIfosfamideIsotretinoinMelphalanTopotecanVincristineVindesineSubstanceCarboplatinCisplatinCyclophosphamideDacarbazineDoxorubicinEtoposide phosphateIfosfamideIsotretinoinMelphalanTopotecanVincristineVindesineSubstanceCarboplatinCisplatinCyclophosphamideDacarbazineDoxorubicinEtoposide phosphateIfosfamideIsotretinoinMelphalanTopotecanVincristineVindesineNo. Substances134 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%MesnaPotassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%MesnaPotassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%MesnaPotassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%MesnaPotassium chlorideNo. Substances67810Protocol classificationTherapy classificationStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorCaron HNDiseaseNeuroblastomNeuroblastom, Kinder unter 1 Jahr oder unter 10 kgNeuroblastom, Kinder unter 1 Jahr oder unter 10 kg und MYCN-Amplifikation, MegatherapieNeuroblastom, Kinder über 1 JahrNeuroblastom, Kinder über 1 Jahr, MegatherapieOriginDCOG NBL 2009Protocols in Revision 11 protocols foundPAED Cisplatin 40 / Etoposide Phosphate 100 / Vindesin 3, Neuroblastoma, N5 (PID2875 V1.1)PAED Cyclophosphamide 150, Neuroblastoma, N7 (PID2883 V1.0)PAED Cyclophosphamide 5, Neuroblastoma, N7 (PID2884 V1.0)PAED Doxorubicin 0.5 / Vincristine 0.025 / Cyclophosphamide 10, Neuroblastoma, N4 (PID2874 V1.0)PAED Doxorubicin 15 / Vincristine 0.75 / Cyclophosphamide 300, Neuroblastoma, N4 (PID2873 V1.0)PAED Isotretinoin 80, Neuroblastoma (PID2889 V1.0)PAED Melphalan 45 / Etoposide Phosphate 40 / Carboplatin 500, Neuroblastoma, autologous Stem Cell Transplantation (PID2887 V1.0)PAED Melphalan 1.5 / Etoposide Phosphate 40 / Carboplatin 16.6, Neuroblastoma, Stem Cell Transplantation, Autologous (PID2888 V1.0)PAED Topotecan 1 / Cyclophosphamide 100 / Etoposide Phosphate 100, Neuroblastoma, N8 (PID2885 V1.1)PAED Vincristine 0.05 / Dacarbazine 6.7 / Ifosfamide 50 / Doxorubicin 1, Neuroblastoma, N6 (PID2882 V1.0)PAED Vincristine 1.5 / Dacarbazine 200 / Ifosfamide 1500 / Doxorubicin 30, Neuroblastoma, N6 (PID2881 V1.0)
